Back to search

Prognostic Effect of Basal-Like Breast Cancers Is Time Dependent: Evidence from Tissue Microarray Studies on a Lymph Node–Negative Cohort

Data up to Jan 2025

Published2008
Citations39
References31

Total Citations Per Year

Abstract

References (31)

Statistical Methods for Rates and Proportions

2003 • 17,930 citations

Molecular portraits of human breast tumours

2000 • 15,445 citations

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

2001 • 10,602 citations

Statistical Methods for Rates and Proportions, 2nd ed

1981 • 3,735 citations

Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma

2004 • 2,644 citations

Prognostic and predictive factors in breast cancer by immunohistochemical analysis.

1998 • 2,121 citations

Breast cancer classification and prognosis based on gene expression profiles from a population-based study

2003 • 2,013 citations

Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer

1999 • 1,991 citations

Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma

2005 • 1,037 citations

Validation of Tissue Microarray Technology in Breast Carcinoma

2000 • 800 citations

Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas

2007 • 605 citations

High‐throughput protein expression analysis using tissue microarray technology of a large well‐characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses

2005 • 597 citations

Expression of Cytokeratins 17 and 5 Identifies a Group of Breast Carcinomas with Poor Clinical Outcome

2002 • 565 citations

neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group.

1998 • 435 citations

Validation of Tissue Microarrays for Immunohistochemical Profiling of Cancer Specimens Using the Example of Human Fibroblastic Tumors

2001 • 399 citations

Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival

2007 • 306 citations

p53 gene mutations and protein accumulation in human ovarian cancer.

1993 • 294 citations

Progesterone receptor by immunohistochemistry and clinical outcome in breast cancer: a validation study

2004 • 283 citations

Tissue microarrays (TMAs) for high-throughput molecular pathology research

2001 • 244 citations

Software Tools for High-Throughput Analysis and Archiving of Immunohistochemistry Staining Data Obtained with Tissue Microarrays

2002 • 202 citations

Neuroendocrine expression in metastaticprostate cancer: Evaluation of high throughput tissue microarrays to detect heterogeneous protein expression

2000 • 183 citations

Discriminating functional and non-functional p53 in human tumours by p53 and MDM2 immunohistochemistry

2005 • 135 citations

p53 null mutations undetected by immunohistochemical staining predict a poor outcome with early-stage non-small cell lung carcinomas.

1999 • 110 citations

The Combination of p53 Mutation and neu/erbB-2 Amplification Is Associated With Poor Survival in Node-Negative Breast Cancer

2003 • 100 citations

Pattern of p53 Gene Mutations in Breast Cancers of Women of the Midwestern United States

1992 • 94 citations

Immunohtstochemical analysis of the p53 oncoprotein on paraffin sections using a series of novel monoclonal antibodies

1993 • 88 citations

Tissue microarray technology: principles, pitfalls and perspectives—lessons learned from hematological malignancies

2005 • 83 citations

Evaluation of HER-2/neu oncogene status in breast tumors on tissue microarrays

2003 • 78 citations

Comparison of HER2/neuStatus Assessed by Quantitative Polymerase Chain Reaction and Immunohistochemistry

2001 • 67 citations

p53 Protein Accumulation in Non-Invasive Lesions Surrounding p53 Mutation Positive Invasive Breast Cancers

2001 • 31 citations

Type of TP53 mutation and ERBB2 amplification affects survival in node-negative breast cancer

2007 • 21 citations

Cited By (0)

No citing papers found in database

Prognostic Effect of Basal-Like Breast Cancers Is Time Dependent: Evidence from Tissue… (2008) – Clinical Cancer Research | Metascience Observatory Explorer